about
Myeloid-derived Suppressor Cells are Necessary for Development of Pulmonary Hypertension.Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations."Only a life lived for others is worth living:" Redox Signaling by Oxygenated Phospholipids in Cell Fate Decisions.Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.NK Cell Exhaustion.The peritoneum: healing, immunity, and diseases.Estrogens drive myeloid-derived suppressor cell accumulation.miRNAs, Melanoma and Microenvironment: An Intricate Network.The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation.Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma.Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy.Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.The dawn of vaccines for cancer prevention.Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.LncRNA RNCR3 promotes Chop expression by sponging miR-185-5p during MDSC differentiation.Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance.Combination Immunotherapy: Taking Cancer Vaccines to the Next Level.S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4-ERK1/2 Signaling.Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors.Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling.Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma.Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma.Acquired immunological imbalance after surgery with cardiopulmonary bypass due to epigenetic over-activation of PU.1/M-CSF.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studiesNative-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineeringTargeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 T cells in the tumor microenvironment
P2860
Q38597953-C448DDDC-24F3-471B-83E7-F8AE33F8CECFQ38600417-F3600F83-7DB9-4A43-9C8D-DBF6ABD10BF3Q38611433-ABD763D0-4AC8-448F-8BF7-30FE8A1A47BDQ38652940-A13924A6-F81A-4E5E-B078-2A531876FE43Q39417307-48997094-1411-461C-BBED-750F13DA4B4CQ39423479-AA3915AB-235E-4E72-B4B3-0CC1195F83E5Q39431541-EAD157A2-FF74-4780-8C30-D0755D32D11FQ39443675-F37C9E7D-E0C6-4D6F-90A7-09202D8CE9E7Q42314777-FD4AC110-1ABA-4DCE-8478-F94C1A9EF3C1Q47152593-38066DB2-C282-44AF-944F-4D22E1B52DCBQ47318813-C1F42E1C-CAC8-472B-A464-8B24D3B3A8E7Q47404669-48CA3D7B-9D29-4727-84A8-5E34088E201DQ47553626-27E7AD1A-52D5-492B-A5C0-EDAFF9D3185EQ47563950-FC08F481-03AE-4247-BC17-0924CDCFB4C7Q47706581-CA38AF52-41A3-4C57-9CE9-B93167E2E74FQ47821123-FA1E721E-042B-4ABE-A2EE-72D9D9E0FDF0Q48207560-188FEAFE-E72F-4DE2-860B-0744174D80EAQ48638999-DCF10D4D-6559-463B-9DA2-8F38F8693FECQ49188150-D7788E10-9802-4917-92A7-57759B7FF9F9Q49401353-B696A6D6-7CAC-4B1B-A8A0-3569B91F7D0CQ49566629-BFE5EBBA-17A0-4FE9-81D7-948CC5162717Q49587589-287962CA-40D1-49DB-827E-709BC6146B2DQ49900625-742B8DCF-D616-4E76-BF2A-37F745996117Q50017138-BADEA433-A64D-490D-B732-2E71717D6C11Q50138585-0DD172B4-153B-43F8-9D86-61573A10AC89Q51761548-76569862-30C4-4C37-AC06-70D086177C64Q52603627-D0D69ED5-FB8F-45D2-B72D-7410DE58B228Q52647750-8E7B18D1-28AD-4EE5-A3BE-A47C3269D09BQ54943714-13BAA10B-F42B-414F-9C05-D3856EF7171BQ55007836-30FFF0CD-E6C0-4A94-A912-52BB85929EEFQ55012882-F3826EA2-6FF6-4C22-A704-538600B89037Q55076188-7F45ABDB-236E-491F-B78A-3D2177ED6195Q55265921-E8D27662-2175-4AD0-A4B7-4BE7BE0E9616Q55361920-1FD4A5E7-FC4C-4758-9C42-64382213D990Q55411543-E942FE8E-447D-444E-802E-DDB5004D0C28Q55443866-E6AB48CD-0DFC-47F5-A93F-263F4AF3C56CQ55542525-62A487EA-4A00-4C20-A86D-55341CA598FCQ57138311-75D6E097-1A78-4249-A5E4-FDC93BAA4126Q57158003-0469FD58-4CF7-41EE-A7EC-76C79EE5A30CQ57476222-C20F153D-FED3-4554-BC2F-19EA1140EE0B
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Myeloid-Derived Suppressor Cells.
@en
type
label
Myeloid-Derived Suppressor Cells.
@en
prefLabel
Myeloid-Derived Suppressor Cells.
@en
P2860
P1476
Myeloid-Derived Suppressor Cells.
@en
P2093
Dmitry I Gabrilovich
P2860
P356
10.1158/2326-6066.CIR-16-0297
P577
2017-01-01T00:00:00Z